Metastatic Transitional Cell Carcinoma
2 clinical trials · Condition
◉ Watch Metastatic Transitional Cell Carcinoma
| Record | Firm | Date |
|---|---|---|
| Sapanisertib in Treating Patients With Locally Advanced or Metastatic Bladder Cancer With TSC1 and/or TSC2 Mutations (NCT03047213) | National Cancer Institute (NCI) | 2017-08-24 |
| Everolimus (RAD001) in Metastatic Transitional Cell Carcinoma of the Urothelium (NCT00805129) | Memorial Sloan Kettering Cancer Center | 2008-12-05 |
Track Metastatic Transitional Cell Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.